Abuse OF Olanzapine by Substance Abusers
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Olanzapine has been used for over a decade for treatment of schizophrenia and bipolar disorder. The drug may have sedative properties for some patients, especially in large doses. The case reported here involves a 25-year-old male who abused olanzapine, both by itself and in combination with other drugs. Also described are the patient's reports of abuse of olanzapine by several of his acquaintances. The potential for abuse of olanzapine by substance abusers is discussed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, the high plasma concentrations of free testosterone in male subjects may contribute to higher CYP3A4 activity, which may be associated with a faster biotransformation of quetiapine, [50] and hence a possible tendency to increase its dosage, in males.”
In the citing paper
“In fact, as quetiapine metabolism is mediated by the human cytochrome CYP3A4, a pharmacokinetic interaction may occur with a variety of drugs, including analgesics, anti-arrhythmia, antibiotics, anticonvulsants, antihistamines, antiparkinsonians, pump inhibitors, steroids, and triptans [50].”
Citations
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
From hospital to community psychiatry
Jones, M. (1970) · Community Mental Health Journal · doi:10.1007/bf01435915 · Cited by 2,043
Olanzapine versus Placebo and Haloperidol
Beasley, C. M., Tollefson, G., Tran, P., Satterlee, W., Sanger, T., & Hamilton, S. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00069-p · Cited by 778
American Journal of Psychiatry 1844-1994
(1994) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615376988 · Cited by 482
Atypical antipsychotics in bipolar depression: potential mechanisms of action.
Yatham, L. N., Goldstein, J. M., Vieta, E., Bowden, C. L., Grunze, H., Post, R. M., Suppes, T. M., & Calabrese, J. R. (2005) · PubMed · Cited by 183
Olanzapine treatment for patients with schizophrenia and substance abuse
Littrell, K. H., Petty, R. G., Hilligoss, N. M., Peabody, C. D., & Johnson, C. G. (2001) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00205-7 · Cited by 110
Pierre, J. M., SHNAYDER, I., Wirshing, D. A., & Wirshing, W. C. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1718 · Cited by 102
First-Episode Schizophrenia: A Focus on Pharmacological Treatment and Safety Considerations
Kelly, D. L., Conley, R. R., & Carpenter, W. T. (2005) · Drugs · doi:10.2165/00003495-200565080-00006 · Cited by 98
A pilot trial of olanzapine for the treatment of cocaine dependence
Kampman, K. M., Pettinati, H. M., Lynch, K. G., Sparkman, T., & O’Brien, C. P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00009-7 · Cited by 81
Gabapentin Abuse in Inmates with Prior History of Cocaine Dependence
Reccoppa, L., Malcolm, R. J., & Ware, M. R. (2004) · American Journal on Addictions · doi:10.1080/10550490490460300 · Cited by 57
Research works printed but not linked: 3
- Delilse J. D., 1990, American Journal of Psychiatry, 147, 1377
- Dilsaver S. C., 1988, Journal of Clinical Psychopharmacology, 8, 14
- Land W., 1991, Hospital & Community Psychiatry, 42, 580
Cited by
Schifano, F., Chiappini, S., Corkery, J., & Guirguis, A. (2018) · Brain Sciences · doi:10.3390/brainsci8040073 · Cited by 93
“According to discussion forums/specialised websites [111], olanzapine is also being used to treat unwanted ‘comedown’ symptoms from drug/alcohol intake [112,113].”
BackgroundThe Benefits of Olanzapine in Palliating Symptoms
Davis, M. P., & Sanger, G. J. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-020-00804-1 · Cited by 57
Chiappini, S., & Schifano, F. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000814 · Cited by 44
Valeriani, G., Corazza, O., Bersani, F. S., Melcore, C., Metastasio, A., Bersani, G., & Schifano, F. (2015) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2431 · Cited by 41
Misuse and Associated Harms of Quetiapine and Other Atypical Antipsychotics
Montebello, M. E., & Brett, J. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_424 · Cited by 28
Metadata
- Authors
- Reeves, R. R.
- Affiliations
- University of Mississippi Medical Center (US)
- Corresponding author
- Reeves, Roy R.
- ORCID
- Reeves, Roy R.
- Venue
- Journal of Psychoactive Drugs
- Publisher
- Informa UK Limited
- Published
- 2007-09
- Volume
- 39
- Issue
- 3
- Pages
- 297-299
- ISSN
- 0279-1072 (ISSN-L)
- 2159-9777
- OpenAlex
- W1984041544
- Cited by
- 22
- References
- 21
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 4 · 2013: 2
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Psychoactive Drugs (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- olanzapine, drug abuse, substance abuse, atypical antipsychotics, polydrug use, sedative effects, schizophrenia, bipolar disorder, recreational drug use
- MeSH terms
- Olanzapine, Adult, Benzodiazepines, Humans, Male, Antipsychotic Agents, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Abuse OF Olanzapine by Substance Abusers. https://app.cochat.ai/papers/10.1080/02791072.2007.10400617
- The paper
- Reeves, R. R. (2007). Abuse OF Olanzapine by Substance Abusers. Journal of Psychoactive Drugs. https://doi.org/10.1080/02791072.2007.10400617
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.